You are here: Industry Insights > MNC

News List

2025 Q1: Oncology Business Competition Among MNCs Xiaobin
June 04, 2025
How did MNCs fare in the oncology field during Q1 of this year?
Next Stop for PD-1? MNC for Subcutaneous Preparation Takes the Lead in Competition, Leading to A More Fierce Domestic Conpetition, but Differentiation is not easy Spur 203/PharmaSources
December 14, 2023
The competition for the subcutaneous formulation of PD-1/PD-L1 inhibitors has been spreading globally for a long time, with Roche and Bristol Myers Squibb currently leading the pack.
MNC ramps up AI pharmaceutical layout, can AI and pharmaceuticals collide to spark "fireworks"? Yefenghong/PharmaSources
October 27, 2023
AI (Artificial Intelligence) pharmaceuticals refer to the use of artificial intelligence technologies such as big data, cloud computing, and deep learning to assist in drug discovery, drug management, efficacy analysis, and other processes.
Under the new policy tilt, how can MNCs increase their investment in China? Yefenghong/PharmaSources
September 08, 2023
On August 13th, the State Council issued the "Opinions on Further Optimizing the Foreign Investment Environment and Increasing the Attractiveness of Foreign Investment" (hereinafter referred to as the "Opinions").
HMNC Brain Health Raises EUR 9 Million firstwordpharma
July 29, 2021
HMNC Brain Health (“HMNC” or the “Company”), a biotech company pioneering the development of personalized therapies in psychiatry powered by predictive companion diagnostics, today announced it has received an additional EUR 9 million EUR from its current
Anupam Rasayan receives Rs 540 crore order from two MNCs dealing in life sciences chemicals expresspharma
May 20, 2021
Anupam Rasayan, custom synthesis and specialty chemical player, informed that it has received and signed contracts amounting to Rs 540 crores from two multinational companies dealing in the fields of life sciences chemicals.